Safety of Human Embryonic Stem Cell (hESC)-Derived Mesenchymal Stem Cells in Interstitial Cystitis

Clinical trial NCT04610359 · UNKNOWN

Trial details

NCT number: NCT04610359
Sponsor: Asan Medical Center
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Interstitial Cystitis Stem Cell Transplant Mesenchymal Stem Cell

Start date: 2020-10-20
Primary completion: 2022-10-01
Enrollment: 3

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.